Navigation Links
Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
Date:10/14/2008

SAN DIEGO, Oct. 14 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has been honored to receive two fast growth awards, Deloitte LLP's San Diego Technology Fast 50 and the San Diego Business Journal 100 Fastest Growing Private Companies, for the fifth consecutive year. The Deloitte Technology Fast 50 is an annual ranking of the 50 fastest growing technology, media, telecommunications, and life sciences companies in the area based on a percentage revenue growth over a five year period. The San Diego Business Journal bases its award on revenue growth over three years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

Althea supports new biopharmaceutical developers and pharmaceutical firms, who require specialized facilities and expertise to manufacture their products under exacting conditions. While year-on-year revenue growth has been driven primarily by its manufacturing services, Althea also provides specialized testing, biomarker development services and has recently launched AltheaDx, a spin-out targeting oncology diagnostics and services.

To qualify for the Deloitte Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2003 and $5,000,000 in 2007, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology.

The San Diego Business Journal selection process included percent revenue growth achieved from 2005 to 2007, required that the company be privately held, based in San Diego County and have a minimum revenue of $200,000 in 2005 in order to be considered for the list.

President and Co-CEO of Althea, Dr. Magda Marquet, added, "Receiving Deloitte's Fast 50 award and the San Diego Business Journal's Fast 100 award for the fifth year in a row is affirmation that we are continuing to listen to our pharmaceutical and biotechnology clients' requests and meet their demands for flexibility, compliance and service in advancing their exciting products. We are grateful for the confidence our growing client base has placed in us, a confidence earned through the dedication and hard work of our employees."

About Althea Technologies, Inc.

Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea's services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, and aseptic filling. For more information, visit http://www.altheatech.com.

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP. Please see http://www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

About The San Diego Business Journal

The San Diego Business Journal is the area's number one source for local, late breaking business news. For over 29 years, the Business Journal has provided in-depth coverage of the banking and finance, real estate, technology, tourism, life sciences and local government sectors, with a healthy dose of small business coverage as well. For more information please visit http://www.sdbj.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
2. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
3. VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29
4. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
5. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
6. Creators of Britains Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008
7. Neptune Technologies & Bioressources Inc. reports first quarter results
8. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
9. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
10. Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.
11. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Research and Markets has announced the addition ... to their offering. ... The study scope includes ... chassis organisms, synthetic cells, production systems), enabling technologies (DNA ... specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... utilize LungDirect for pulmonary nodule patient management. In addition ... or a spot on the lung, UCHealth looks to ... manual data entry. Stephanie Brown, RN ... my nodule patients with an Excel spreadsheet, which was ...
(Date:2/16/2017)... WARRINGTON, Pa. , Feb. 16, 2017 /PRNewswire/ ... a biotechnology company focusing on developing aerosolized KL4 ... data from a preclinical influenza study showed that ... overall survival in a well-established preclinical animal model. ... to a growing body of evidence that supports ...
(Date:2/15/2017)... ... , ... Executive search firm, Slone Partners, announces the placement ... is a veteran life sciences and molecular diagnostics executive with extensive commercialization experience. ... disease risk in future generations. In his new role, Matt will be responsible ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)...  EyeLock LLC, a market leader of iris-based identity ... What You Should Know About Biometrics in the Cloud ... is a growing concern. In traditional schemes, cryptography is ... authentication schemes such as username/password suffer from inherent weaknesses. ... an elegant solution to the problem of high-security user ...
Breaking Biology News(10 mins):